# Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome

> **NCT01445041** · PHASE1 · TERMINATED · sponsor: **Michael Cotten** · enrollment: 7 (actual)

## Conditions studied

- Hypoplastic Left Heart Syndrome

## Interventions

- **BIOLOGICAL:** Autologous Umbilical Cord Blood
- **BIOLOGICAL:** Autologous Umbilical Cord Blood

## Key facts

- **NCT ID:** NCT01445041
- **Lead sponsor:** Michael Cotten
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-09-01
- **Primary completion:** 2016-04-15
- **Final completion:** 2016-04-15
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Funding Period Ended
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01445041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01445041, "Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01445041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*